Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

During the Trading Day
12.11 +0.17 / +1.42%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
12.02 -0.0892 / -0.74%
 
Volume: 33.4K
No recent news for Novavax Inc.

Today’s Trading

Previous close11.94
Today’s open12.23
Day’s range11.76 - 12.25
Volume2,990,507
Average volume (3 months)3,534,837
Market cap$3.2B
Dividend yield--
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-9.99%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book12.42

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+1.85+2.52%
KITEKite Pharma Inc+0.19+0.27%
HALOHalozyme Therapeutic...-0.30-1.28%
OPHTOphthotech Corp+0.23+0.34%
Data as of 4:14pm ET, 07/30/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts